AI gains ground in care, but human oversight remains central

CURRENT FULL VERSION: Artificial intelligence is gaining ground across healthcare, but the current evidence still supports a cautious framing: powerful tool, not replacement. That conclusion runs through the source material and the broader literature. Recent reviews point to meaningful gains in narrow tasks, especially in imaging, laboratory workflows, documentation, and digital support tools, yet they also underline the same unresolved issues: models that perform well in curated datasets may not hold up across populations, clinics, or workflows, and human oversight remains essential. A recent systematic review outside veterinary medicine reached a similar bottom line in a more specific diagnostic setting: AI-based methods for impacted canine assessment showed some promising estimates in a small subset of studies, but limited sample sizes, heterogeneity, scarce external validation, and inconsistent reporting meant the evidence was not strong enough to support clinically decisive use. (pubmed.ncbi.nlm.nih.gov)

In veterinary medicine, that tension is becoming more visible because adoption is no longer theoretical. Companion animal AI is expanding from diagnostic support into remote monitoring, behavior analysis, feeding systems, parasite detection, and veterinary support services, according to a 2025 review in Research in Veterinary Science. At the same time, practice software vendors are increasingly marketing AI for operational tasks such as SOAP note generation, intake, record summarization, and communication workflows, reflecting a shift from experimental use to embedded practice infrastructure. (pubmed.ncbi.nlm.nih.gov)

That broader shift helps explain why the “not a replacement” framing resonates. In human healthcare, narrative reviews emphasize that AI systems are task-specific and dependent on the quality and representativeness of the data they receive. Their limitations are practical as much as technical: weak out-of-distribution performance, vulnerability to bias, lack of physical exam context, and unresolved legal and ethical questions. Even in radiology, one of the most mature AI application areas, recent literature describes AI as something that can improve speed and consistency, but still requires clinician verification and careful workflow integration. The impacted-canine review adds a useful reminder that conventional tools can still set the practical standard: CBCT outperformed two-dimensional panoramic radiography for diagnosis, and the authors concluded that imaging choices should still be guided by established clinical principles such as ALARA rather than by enthusiasm for newer AI methods. (pubmed.ncbi.nlm.nih.gov)

Veterinary attitudes appear to be moving faster than veterinary training. A 2026 Journal of Veterinary Internal Medicine survey of ACVIM and ECVIM-CA members found respondents were generally optimistic that AI tools will improve veterinary medicine and be part of their careers. But a separate 2026 PubMed-indexed survey reported that 90.5% of veterinary workers had no or minimal formal AI training, and 66.1% described only a basic understanding of AI. That combination, interest without deep preparation, is likely to shape the next stage of adoption inside clinics and referral centers. (academic.oup.com)

Industry messaging is already focused on workflow relief. Digitail’s recent materials present AI as a way to move beyond transcription into broader automation across intake, documentation, and communication, and the company has also argued that veterinary groups may soon need dedicated AI leadership. Those claims come from a commercial source and should be read with that in mind, but they line up with a wider trend: the first veterinary AI wins may come from reducing administrative burden rather than replacing diagnostic judgment. That matters in a profession where burnout, staffing strain, and documentation load remain persistent operational problems. (digitail.com)

Why it matters: For veterinary professionals, the practical question isn’t whether AI is coming. It’s where it can be trusted, how it should be supervised, and what evidence should be required before it influences care. In the near term, the strongest use cases are likely to be narrow and assistive, including imaging support, record summarization, clinical documentation, and pattern recognition in large datasets. The risk is that convenience outpaces validation. If teams adopt tools without understanding training data, failure modes, or bias, AI can create a false sense of confidence rather than a true efficiency gain. The same caution shows up in adjacent evidence reviews: even where AI appears promising, authors are still calling for larger prospective studies, longer follow-up, standardized reporting, and rigorous external validation and calibration before those systems should influence clinical decisions. That makes governance, staff education, and explicit review workflows just as important as the tool itself. (pubmed.ncbi.nlm.nih.gov)

Regulatory signals from human healthcare also matter, even if veterinary oversight is less developed. In January 2025, FDA issued draft guidance for AI-enabled medical devices covering lifecycle management, transparency, bias, and documentation, and it has continued to emphasize real-world performance monitoring and change control planning for adaptive systems. Those frameworks are aimed at human medicine, but they offer a useful roadmap for veterinary stakeholders evaluating AI vendors and internal governance. In practice, clinics, health systems, and industry groups may increasingly ask the same questions regulators are asking: how was the model trained, how is performance monitored, what happens when it updates, and when must a veterinarian override it? (fda.gov)

What to watch: The next phase will likely bring more veterinary-specific validation studies, more workforce surveys, and sharper scrutiny of which products deliver measurable clinical or operational benefit in real practice. Expect growth in assistive tools first, especially documentation and decision support, alongside rising pressure for transparency, training, and outcome data before AI moves deeper into frontline care. Just as important, expect more demand for evidence that AI can outperform or meaningfully complement existing standards of care, not just benchmark well in isolated datasets. (academic.oup.com)